ロード中...
The potential effects of clinical antidiabetic agents on SARS‐CoV‐2
BACKGROUND: Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), is currently posing significant threats to public health worldwide. It is notable that a substantial proportion of patients with sever COVID‐19 have coexisting diabetic conditions...
保存先:
| 出版年: | J Diabetes |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley Publishing Asia Pty Ltd
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753367/ https://ncbi.nlm.nih.gov/pubmed/33210826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1753-0407.13135 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|